SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-359368"
 

Sökning: id:"swepub:oai:DiVA.org:uu-359368" > Reporting of patien...

  • Goey, Kaitlyn K. H.Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands (författare)

Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer : A systematic review

  • Artikel/kapitelEngelska2018

Förlag, utgivningsår, omfång ...

  • Elsevier BV,2018
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-359368
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-359368URI
  • https://doi.org/10.1016/j.ejca.2018.03.026DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:for swepub-publicationtype

Anmärkningar

  • Background: Patient characteristics and stratification factors are important factors influencing trial outcomes. Uniform reporting on these parameters would facilitate cross-study comparisons and extrapolation of trial results to clinical practice. In 2007, standardisation on patient characteristics reporting and stratification in metastatic colorectal cancer (mCRC) trials was proposed. We investigated the reporting of prognostic factors and implementation of this proposal in mCRC trials published from 2005 to 2016.Methods: We searched PubMed and Embase (January 2005 – June 2016) for first-line phase 3 mCRC trials. Patient characteristics reporting and use of stratification factors were extracted and analysed for adherence to the proposal from 2007.Results: Sixty-seven trials (35,315 patients) were identified, reporting 48 different patient characteristics (median: 9 [range: 5–18] per study). Age, gender, performance status (PS), primary tumour site and adjuvant chemotherapy were frequently reported (87%–100%), in contrast to laboratory values, such as alkaline phosphatase, lactate dehydrogenase and white blood cell count (10%–25%). We identified 29 different stratification factors (median: 3 [range: 1–9] per study). The most common strata were PS and treatment centre (>60%). A median of 8/12 (range: 4–11) of the proposed parameters was reported. Although the percentage of studies reporting each factor slightly increased over time, there was no significant correlation between publication year and adherence to the proposal from 2007.Conclusions: We observed persistent heterogeneity in the reporting of patient characteristics and use of stratification factors in first-line mCRC trials. The proposal from 2007 has not led to increased uniformity of patient characteristics reporting and use of stratification over time. There is an urgent need to address this issue to improve the interpretation of trial results.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Mahmoud, RemiUniv Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands (författare)
  • Sørbye, HalfdanHaukeland Hosp, Dept Oncol, Bergen, Norway; Haukeland Hosp, Dept Clin Sci, Bergen, Norway (författare)
  • Glimelius, BengtUppsala universitet,Experimentell och klinisk onkologi(Swepub:uu)bengglim (författare)
  • Köhne, Claus-HenningKlinikum Oldenburg, Univ Clin Internal Med Oncol & Hematol, Oldenburg, Germany (författare)
  • Sargent, Daniel J.Mayo Clin, Ctr Canc, Div Biomed Stat & Informat, Rochester, MN USA (författare)
  • Punt, Cornelis J. A.Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, Amsterdam, Netherlands (författare)
  • van Oijen, Martijn G. H.Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, Amsterdam, Netherlands (författare)
  • Koopman, MiriamUniv Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands (författare)
  • Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, NetherlandsHaukeland Hosp, Dept Oncol, Bergen, Norway; Haukeland Hosp, Dept Clin Sci, Bergen, Norway (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:European Journal of Cancer: Elsevier BV96, s. 115-1240959-80491879-0852

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy